切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2017, Vol. 06 ›› Issue (04) : 320 -323. doi: 10.3877/cma.j.issn.2095-3224.2017.04.011

所属专题: 文献

综述

家族性结直肠癌X型研究进展
季午阳1, 吴斌1,()   
  1. 1. 100730 中国医学科学院 北京协和医院基本外科
  • 收稿日期:2017-02-21 出版日期:2017-08-25
  • 通信作者: 吴斌
  • 基金资助:
    协和青年基金--中央高校基本科研业务费专项资金资助项目(No.3332015094)

Advances in the diagnosis and treatment of familial colorectal cancer type X

Wuyang Ji1, Bin Wu1,()   

  1. 1. Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
  • Received:2017-02-21 Published:2017-08-25
  • Corresponding author: Bin Wu
  • About author:
    Corresponding author: Wu Bin, Email:
引用本文:

季午阳, 吴斌. 家族性结直肠癌X型研究进展[J/OL]. 中华结直肠疾病电子杂志, 2017, 06(04): 320-323.

Wuyang Ji, Bin Wu. Advances in the diagnosis and treatment of familial colorectal cancer type X[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2017, 06(04): 320-323.

结直肠癌是中国乃至全世界最主要的癌症死亡原因之一,将近20%的结直肠癌有家族史,但仅5%的结直肠癌可能与基因突变这一因素相关。在一部分符合阿姆斯特丹诊断标准Ⅱ的家庭中,却并未发现遗传性非息肉性结直肠癌的典型遗传学表现——微卫星不稳定(MSI)和DNA错配修复基因(MMR)突变,这些患者则被称作家族性结直肠癌X型。我们通过回顾近年的相关文献研究,对家族性结直肠癌X型的临床特点及遗传学研究进展进行综述。

Colorectal cancer is a major cause of morbidity and mortality in China and also in the whole world. Up to 20% of CRCs have evidence of a familial component and about 5% are thought to be due to the well-characterized inherited mutations. In some of the families fulfilling the Amsterdam criteria for hereditary non-polyposis colorectal cancer, colorectal cancers are microsatellite stable and DNA mismatchrepair (MMR) gene mutations are not found. These families were designated as familial colorectal cancer type X (FCCTX). This review will give a full-scale view of FCCTX among multi-dimension, based on the recent articles all over the world.

[1]
Siegel RL, Miller KD, Jemal A.Cancer Statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1):7-30.
[2]
Favoriti P, Carbone G, Greco M, et al. Worldwide burden of colorectal cancer: a review[J]. Updates Surg, 2016, 68(1):7-11.
[3]
Francisco I, Albuquerque C, Lage P, et al. Familial colorectal cancer type X syndrome: two distinct molecular entities?[J]. Fam Cancer, 2011, 10(4):623–631.
[4]
Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X[J]. JAMA, 2005, 293(16):1979–1985.
[5]
Klarskov L, Holck S, Bernstein I. Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome[J]. J Clin Pathol, 2012, 65(4):352-356.
[6]
Shiovitz S, Copeland WK, Passarelli MN, et al. Characterisation of Familial Colorectal Cancer Type X, Lynch syndrome, and non-familial colorectal cancer[J]. Br J Cancer, 2014, 111(3):598-602.
[7]
Mueller-Koch Y, Vogelsang H, Kopp R, et al. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer[J]. Gut, 2005, 54(12):1733-1740.
[8]
Dominguez-Valentin M, Therkildsen C, Da Silva S. Familial colorectal cancer type X: genetic profiles and phenotypic features[J]. Mod Pathol, 2015, 28(1):30-36.
[9]
Valle L. Genetic predisposition to colorectal cancer: Where we standand future perspectives[J]. World J Gastroenterol, 2014, 20(29):9828-9849.
[10]
Woods MO, Younghusband HB, Parfrey PS, et al. The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease[J]. Gut, 2010, 59(10):1369-1377.
[11]
Jasperson KW, Tuohy TM, Neklason DW, et al. Hereditary and familial colon cancer[J]. Gastroenterology, 2010, 138(6), 2044-2058.
[12]
Nieminen TT, Abdel-Rahman WM, Ristimäki A, et al. BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency[J]. Gastroenterology, 2011, 141(1):e23-e26.
[13]
Nieminen TT, O′Donohue MF, Wu Y, et al. Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency[J]. Gastroenterology, 2014, 147(3):595-598.
[14]
Schulz E, Klampfl P, Holzapfel S, et al. Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X[J]. Nat Commun, 2014, 5:5191.
[15]
Sánchez-Tomé E, Rivera B, Perea J, et al. Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X[J]. J Gastroenterol, 2015, 50(6):657-666.
[16]
Therkildsen C, Jönsson G, Dominguez-Valentin M, et al. Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer[J]. Eur J Cancer, 2013, 49(6):1226-1235.
[17]
Wei C, Peng B, Han Y, et al. Mutations of HNRNPA0and WIF1 predispose members of a large family to multiple cancers[J]. Fam Cancer, 2015, 14(2):297-306.
[18]
Stoffel EM, Mangu PB, Gruber SB, et al.Hereditary colorectal cancer syndromes: American society of clinical oncology clinical practice guideline endorsement of the familial risk – colorectal cancer: European Society for Medical Oncology clinical practice guidelines[J]. J Clin Oncol, 2015, 33(2):209-217.
[19]
Jover R, Castells A. Molecular information defines a new entity of hereditary colorectal cancer[J]. Gastroenterology, 2008, 134(3):888-889.
[1] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[2] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[3] 谢丽春, 欧庆芬, 张秋萍, 叶升. 简化和标准肝脏MRI方案在结直肠癌肝转移患者随访中的临床应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 434-437.
[4] 施烨鑫, 马翔, 鲁明, 夏青城, 王鹏超, 宋青雨, 赵庆洪. 腹腔镜下结直肠肿瘤定位研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 463-466.
[5] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[6] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[7] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[8] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[9] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[10] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[11] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[12] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[13] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[14] 季鹏程, 鄂一民, 陆晨, 喻春钊. 循环外泌体相关生物标志物在结直肠癌诊断中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 265-273.
[15] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?